EKF Ekf Diagnostics Holdings Plc

TIDMEKF

RNS Number : 9062X

EKF Diagnostics Holdings PLC

02 May 2019

EKF Diagnostics Holdings plc

("EKF" or the "Company")

Result of AGM

EKF Diagnostics Holdings (AIM: EKF), the AIM quoted point-of-care business, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

Enquiries:

 
EKF Diagnostics Holdings plc                       www.ekfdiagnostics.com 
Christopher Mills, Non-Executive Chairman              Tel: 029 2071 0570 
Julian Baines, CEO 
Richard Evans, FD & COO 
 
N+1 Singer (Nomad & Broker)                            Tel: 020 7496 3000 
Aubrey Powell / Lauren Kettle / George Tzimas 
 (Corporate Finance) 
 Tom Salvesen (Corporate Broking) 
 
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com 
Paul McManus/ Lianne Cawthorne                 Mob: 07980 541 893 / 07584 
                                                                  391 303 
 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGSSAFSEFUSEFI

(END) Dow Jones Newswires

May 02, 2019 06:21 ET (10:21 GMT)

Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2024 to May 2024

Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From May 2023 to May 2024